Article Details

J&J nabs FDA okay for BCMA bispecific Tecvayli - - Pharmaphorum

Retrieved on: 2022-10-26 09:12:41

Tags for this article:

Click the tags to see associated articles and topics

J&J nabs FDA okay for BCMA bispecific Tecvayli - - Pharmaphorum. View article details on hiswai:

Excerpt

FDA approves the first BCMA-targeted bispecific antibody, J&J's Tecvayli, ... immunomodulatory drug, and anti-CD38 monoclonal antibody.

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up